Small Cap IR - PSID New Marketing Agreement Continues Positive Progression
Jun 18, 2015, 07:00 ET
NEW YORK, June 18, 2015 /PRNewswire/ -- PositiveID Corp. (OTCQB: PSID) develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The company focuses on microfluidic systems for the automated preparation of and performance of biological assays for the detection of biological threats at high-value locations and analyzes samples in a medical environment. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company's M-BAND technology, developed under contract with the U.S. DHS Science & Technology directorate, is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days.
Direct View Holdings, Inc. is a leader in all levels of video surveillance, coupled with PSID's Firefly Dx technology, offers Homeland Security and first responders a potent security solution.
For a brief report with analyst comments and recommendation on PSID please follow the link. There is no cost obligation required to view analyst brief.
Copy and paste to browser may be required.
About Small Cap IR
We make the connection between sophisticated investors and high quality small cap companies. An issuer of reports written research analysts who provide an opinion of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. For more information and services provided beyond this release please use contact information provided below.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. If you notice any errors or omissions, please notify us below. A full disclaimer can be found by viewing the analyst report.
CONTACT: [email protected]
SOURCE Small Cap IR
Share this article